SREBF2 and nonpapillary renal cell carcinoma: Genetic and pharmacological inhibition of SREBF1 and SREBF2 activity also reduced ccRCC proliferation, suggesting that effects on lipid metabolism explain at least partially the phenotypic consequences of KLF6 depletion, although our results do not exclude the possibility that KLF6 promotes ccRCC growth through other mechanisms as well.